"The Global Pharmaceutical Gelatin Market was valued at USD 1.73 billion in 2025 and is projected to reach USD 3.1 billion by 2034, growing at a CAGR of 6.73%."
The Pharmaceutical Gelatin Market plays a critical role in the global pharmaceutical supply chain, serving as a key excipient in the manufacturing of capsules, tablets, plasma expanders, wound dressings, and vaccines. Gelatin is derived mainly from collagen obtained from animal by-products and is valued for its biocompatibility, safety, and thermo-reversible gelling properties. It is extensively used in hard and soft gelatin capsules, which account for a significant share of oral drug delivery systems due to their convenience, controlled release properties, and enhanced bioavailability. The growing demand for encapsulated drugs, aging populations, rising prevalence of chronic diseases, and regulatory approvals for gelatin-based formulations are contributing significantly to the expansion of this market.
The market is witnessing steady technological advancements such as the development of low-endotoxin and halal/kosher-certified gelatin variants to cater to global regulatory and ethical standards. Additionally, innovations in crosslinking technologies and capsule production lines are enhancing gelatin’s pharmaceutical performance. North America and Europe dominate the market due to their advanced pharmaceutical industries and R&D spending, while Asia Pacific is emerging as a high-growth region driven by increasing generic drug production and contract manufacturing. However, concerns related to animal-sourced gelatin, religious constraints, and potential disease transmission risks are prompting investments into alternative sources like fish gelatin and plant-based substitutes, gradually reshaping future market dynamics.
North America Pharmaceutical Gelatin MarketIn North America, the pharmaceutical gelatin market benefits from a well-established pharmaceutical manufacturing infrastructure and growing preference for capsule-based drug delivery systems. The region is witnessing increasing investment in gelatin-based advanced drug formulations, including sustained-release and targeted delivery systems. Regulatory emphasis on clean-label, BSE-free, and traceable gelatin sources is prompting manufacturers to upgrade their production protocols. Technological innovations in capsule-filling machinery and clinical advancements in oncology and specialty therapies continue to create opportunities for gelatin applications. Moreover, the rising demand for nutritional supplements and OTC products also supports consistent market expansion across the United States and Canada.
Asia Pacific Pharmaceutical Gelatin MarketThe Asia Pacific market presents high growth potential, driven by large-scale pharmaceutical production, expanding generics sector, and cost-effective manufacturing. Countries such as China and India are key contributors, with increasing domestic demand and strong export-oriented pharma manufacturing capacities. Local gelatin producers are scaling operations to meet the surging needs of pharmaceutical clients, while compliance with global safety and halal standards remains a focus area. The region is also witnessing growing adoption of softgel technologies in nutraceuticals and traditional medicine integration. Rising healthcare access and policy-driven pharma investments are expected to propel further market penetration across Southeast Asia and Australasia.
Europe Pharmaceutical Gelatin MarketEurope holds a significant share in the pharmaceutical gelatin landscape, backed by stringent quality regulations, high adoption of capsule formulations, and increasing demand for premium-grade gelatin with traceable sourcing. The market is supported by mature pharmaceutical companies and strong R&D in complex therapies. Preference for vegetarian and alternative gelatin sources is emerging, influencing new product development in ethical and dietary-compliant formulations. Leading gelatin manufacturers in the region are investing in sustainable supply chains and bio-based gelatin alternatives. Additionally, the aging population and growing emphasis on chronic disease management are catalyzing the use of gelatin in a broad range of therapeutic categories.
Key Insights
The pharmaceutical gelatin market is primarily driven by the growing demand for capsule-based drug delivery, with gelatin being the preferred excipient for manufacturing both hard and soft capsules due to its excellent gelling, film-forming, and digestibility characteristics.
Soft gelatin capsules are increasingly adopted for liquid or oil-based formulations in therapeutic areas like pain management, vitamin supplements, and oncology, offering superior patient compliance and bioavailability compared to conventional solid dosage forms.
Major pharmaceutical players are investing in research to improve gelatin’s performance in sustained release and targeted drug delivery, enhancing its appeal for high-value applications such as oncology, cardiovascular, and gastroenterology treatments.
The market is witnessing a rise in demand for gelatin types that meet halal, kosher, and BSE-free certifications, especially from regions with strict dietary or ethical compliance requirements such as the Middle East, Asia, and parts of Europe.
Asia Pacific is emerging as a major production and consumption hub, with countries like India and China expanding their pharmaceutical manufacturing bases and offering cost-effective gelatin production through favorable raw material availability.
Pharmaceutical-grade gelatin manufacturers are focusing on reducing endotoxin levels and microbial contamination to meet stringent quality standards, particularly for injectable formulations and plasma expanders used in critical care.
Technological advancements in capsule-filling equipment and automation are enabling high-speed, high-precision production of gelatin capsules, supporting the scalability of production for large-volume prescription and OTC drugs.
While bovine and porcine gelatin dominate the market, fish gelatin is gaining attention due to its compatibility with religious dietary laws and reduced risk of zoonotic disease transmission, expanding its adoption in specialty drug formulations.
The demand for personalized medicine is influencing the development of customized gelatin formulations that allow for precise drug dosing, rapid dissolution, and enhanced patient-centric treatment approaches.
Regulatory authorities in North America and Europe are increasingly enforcing traceability and sustainability in gelatin sourcing, prompting manufacturers to implement transparent supply chain practices and responsible animal sourcing programs.
Market Scope
| Parameter | Detail |
|---|---|
| Base Year | 2024 |
| Estimated Year | 2025 |
| Forecast Period | 2026-2034 |
| Market Size-Units | USD billion |
| Market Splits Covered | By Type , By Function , By Source , By Application |
| Countries Covered | North America (USA, Canada, Mexico) Europe (Germany, UK, France, Spain, Italy, Rest of Europe) Asia-Pacific (China, India, Japan, Australia, Rest of APAC) The Middle East and Africa (Middle East, Africa) South and Central America (Brazil, Argentina, Rest of SCA) |
| Analysis Covered | Latest Trends, Driving Factors, Challenges, Supply-Chain Analysis, Competitive Landscape, Company Strategies |
| Customization | 10 % free customization (up to 10 analyst hours) to modify segments, geographies, and companies analyzed |
| Post-Sale Support | 4 analyst hours, available up to 4 weeks |
| Delivery Format | The Latest Updated PDF and Excel Datafile |
Pharmaceutical Gelatin Market Segmentation
By Type
- Type A
- Type B
By Function
- Stabilizing Agent
- Thickening Agent
- Gelling Agent & other function
By Source
- Porcine
- Bovine Skin
- Bovine Bone
- Marine
- Poultry
By Application
- Hard Capsules
- Softgel Capsules
- Tablets
- Absorbable Hemostats
- Other Applications
By Geography
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Spain, Italy, Rest of Europe)
- Asia-Pacific (China, India, Japan, Australia, Vietnam, Rest of APAC)
- The Middle East and Africa (Middle East, Africa)
- South and Central America (Brazil, Argentina, Rest of SCA)
Key Companies Covered
GELITA AG, Rousselot (Darling Ingredients Inc.), PB Leiner (Tessenderlo Group), Nitta Gelatin Inc., Weishardt Holding SA, LAPI Gelatine S.p.A., Italgelatine S.r.l., Trobas Gelatine B.V., Sterling Gelatin (Sterling Biotech), India Gelatine & Chemicals Ltd., Funingpu Biotechnology, Gelco International, Xiamen Gelken Gelatin Co. Ltd., Lonza (Capsugel), Catalent Pharma Solutions, Norland Products Inc., I gelatine SA, Gelnex Pharmaceuticals, Bio‑Gelatin GmbH, Eastman Chemical Company.Recent Developments
- July 2025 – Gelita AG
Gelita AG expanded its pharmaceutical-grade gelatin production facility in Germany to meet rising global demand for high-purity gelatin used in softgel capsules and specialty drug delivery systems. - June 2025 – Nitta Gelatin
Nitta Gelatin announced the development of a new pharmaceutical gelatin grade with enhanced solubility and improved dissolution properties, targeting high-precision therapeutic applications. - May 2025 – PB Leiner
PB Leiner launched an eco-friendly pharmaceutical gelatin line focused on sustainable sourcing and low environmental impact, aligned with the growing demand for green manufacturing in drug formulations. - April 2025 – Sterling Gelatin
Sterling Gelatin commissioned a new production line in India dedicated to BSE-free pharmaceutical gelatin, aiming to cater to regulated export markets and support India's expanding capsule manufacturing sector. - March 2025 – Rousselot
Rousselot introduced a pharmaceutical gelatin portfolio designed for rapid-dissolution capsules, enhancing bioavailability for active pharmaceutical ingredients across multiple therapeutic areas.
What You Receive
• Global Pharmaceutical Gelatin market size and growth projections (CAGR), 2024- 2034• Impact of recent changes in geopolitical, economic, and trade policies on the demand and supply chain of Pharmaceutical Gelatin.
• Pharmaceutical Gelatin market size, share, and outlook across 5 regions and 27 countries, 2025- 2034.
• Pharmaceutical Gelatin market size, CAGR, and Market Share of key products, applications, and end-user verticals, 2025- 2034.
• Short and long-term Pharmaceutical Gelatin market trends, drivers, restraints, and opportunities.
• Porter’s Five Forces analysis, Technological developments in the Pharmaceutical Gelatin market, Pharmaceutical Gelatin supply chain analysis.
• Pharmaceutical Gelatin trade analysis, Pharmaceutical Gelatin market price analysis, Pharmaceutical Gelatin Value Chain Analysis.
• Profiles of 5 leading companies in the industry- overview, key strategies, financials, and products.
• Latest Pharmaceutical Gelatin market news and developments.
The Pharmaceutical Gelatin Market international scenario is well established in the report with separate chapters on North America Pharmaceutical Gelatin Market, Europe Pharmaceutical Gelatin Market, Asia-Pacific Pharmaceutical Gelatin Market, Middle East and Africa Pharmaceutical Gelatin Market, and South and Central America Pharmaceutical Gelatin Markets. These sections further fragment the regional Pharmaceutical Gelatin market by type, application, end-user, and country.
1.1 List of Tables
1.2 List of Figures
2. Pharmaceutical Gelatin Market Latest Trends, Drivers and Challenges, 2024- 2034
2.1 Pharmaceutical Gelatin Market Overview
2.2 Market Strategies of Leading Pharmaceutical Gelatin Companies
2.3 Pharmaceutical Gelatin Market Insights, 2024- 2034
2.3.1 Leading Pharmaceutical Gelatin Types, 2024- 2034
2.3.2 Leading Pharmaceutical Gelatin End-User industries, 2024- 2034
2.3.3 Fast-Growing countries for Pharmaceutical Gelatin sales, 2024- 2034
2.4 Pharmaceutical Gelatin Market Drivers and Restraints
2.4.1 Pharmaceutical Gelatin Demand Drivers to 2034
2.4.2 Pharmaceutical Gelatin Challenges to 2034
2.5 Pharmaceutical Gelatin Market- Five Forces Analysis
2.5.1 Pharmaceutical Gelatin Industry Attractiveness Index, 2024
2.5.2 Threat of New Entrants
2.5.3 Bargaining Power of Suppliers
2.5.4 Bargaining Power of Buyers
2.5.5 Intensity of Competitive Rivalry
2.5.6 Threat of Substitutes
3. Global Pharmaceutical Gelatin Market Value, Market Share, and Forecast to 2034
3.1 Global Pharmaceutical Gelatin Market Overview, 2024
3.2 Global Pharmaceutical Gelatin Market Revenue and Forecast, 2024- 2034 (US$ billion)
3.3 Global Pharmaceutical Gelatin Market Size and Share Outlook By Product, 2024- 2034
3.4 Global Pharmaceutical Gelatin Market Size and Share Outlook By Application, 2024- 2034
3.5 Global Pharmaceutical Gelatin Market Size and Share Outlook By End User, 2024- 2034
3.6 Global Pharmaceutical Gelatin Market Size and Share Outlook By Technology, 2024- 2034
3.7 Global Pharmaceutical Gelatin Market Size and Share Outlook by Region, 2024- 2034
4. Asia Pacific Pharmaceutical Gelatin Market Value, Market Share and Forecast to 2034
4.1 Asia Pacific Pharmaceutical Gelatin Market Overview, 2024
4.2 Asia Pacific Pharmaceutical Gelatin Market Revenue and Forecast, 2024- 2034 (US$ billion)
4.3 Asia Pacific Pharmaceutical Gelatin Market Size and Share Outlook By Product, 2024- 2034
4.4 Asia Pacific Pharmaceutical Gelatin Market Size and Share Outlook By Application, 2024- 2034
4.5 Asia Pacific Pharmaceutical Gelatin Market Size and Share Outlook By End User, 2024- 2034
4.6 Asia Pacific Pharmaceutical Gelatin Market Size and Share Outlook By Technology, 2024- 2034
4.7 Asia Pacific Pharmaceutical Gelatin Market Size and Share Outlook by Country, 2024- 2034
5. Europe Pharmaceutical Gelatin Market Value, Market Share, and Forecast to 2034
5.1 Europe Pharmaceutical Gelatin Market Overview, 2024
5.2 Europe Pharmaceutical Gelatin Market Revenue and Forecast, 2024- 2034 (US$ billion)
5.3 Europe Pharmaceutical Gelatin Market Size and Share Outlook By Product, 2024- 2034
5.4 Europe Pharmaceutical Gelatin Market Size and Share Outlook By Application, 2024- 2034
5.5 Europe Pharmaceutical Gelatin Market Size and Share Outlook By End User, 2024- 2034
5.6 Europe Pharmaceutical Gelatin Market Size and Share Outlook By Technology, 2024- 2034
5.7 Europe Pharmaceutical Gelatin Market Size and Share Outlook by Country, 2024- 2034
6. North America Pharmaceutical Gelatin Market Value, Market Share and Forecast to 2034
6.1 North America Pharmaceutical Gelatin Market Overview, 2024
6.2 North America Pharmaceutical Gelatin Market Revenue and Forecast, 2024- 2034 (US$ billion)
6.3 North America Pharmaceutical Gelatin Market Size and Share Outlook By Product, 2024- 2034
6.4 North America Pharmaceutical Gelatin Market Size and Share Outlook By Application, 2024- 2034
6.5 North America Pharmaceutical Gelatin Market Size and Share Outlook By End User, 2024- 2034
6.6 North America Pharmaceutical Gelatin Market Size and Share Outlook By Technology, 2024- 2034
6.7 North America Pharmaceutical Gelatin Market Size and Share Outlook by Country, 2024- 2034
7. South and Central America Pharmaceutical Gelatin Market Value, Market Share and Forecast to 2034
7.1 South and Central America Pharmaceutical Gelatin Market Overview, 2024
7.2 South and Central America Pharmaceutical Gelatin Market Revenue and Forecast, 2024- 2034 (US$ billion)
7.3 South and Central America Pharmaceutical Gelatin Market Size and Share Outlook By Product, 2024- 2034
7.4 South and Central America Pharmaceutical Gelatin Market Size and Share Outlook By Application, 2024- 2034
7.5 South and Central America Pharmaceutical Gelatin Market Size and Share Outlook By End User, 2024- 2034
7.6 South and Central America Pharmaceutical Gelatin Market Size and Share Outlook By Technology, 2024- 2034
7.7 South and Central America Pharmaceutical Gelatin Market Size and Share Outlook by Country, 2024- 2034
8. Middle East Africa Pharmaceutical Gelatin Market Value, Market Share and Forecast to 2034
8.1 Middle East Africa Pharmaceutical Gelatin Market Overview, 2024
8.2 Middle East and Africa Pharmaceutical Gelatin Market Revenue and Forecast, 2024- 2034 (US$ billion)
8.3 Middle East Africa Pharmaceutical Gelatin Market Size and Share Outlook By Product, 2024- 2034
8.4 Middle East Africa Pharmaceutical Gelatin Market Size and Share Outlook By Application, 2024- 2034
8.5 Middle East Africa Pharmaceutical Gelatin Market Size and Share Outlook By End User, 2024- 2034
8.6 Middle East Africa Pharmaceutical Gelatin Market Size and Share Outlook By Technology, 2024- 2034
8.7 Middle East Africa Pharmaceutical Gelatin Market Size and Share Outlook by Country, 2024- 2034
9. Pharmaceutical Gelatin Market Structure
9.1 Key Players
9.2 Pharmaceutical Gelatin Companies - Key Strategies and Financial Analysis
9.2.1 Snapshot
9.2.3 Business Description
9.2.4 Products and Services
9.2.5 Financial Analysis
10. Pharmaceutical Gelatin Industry Recent Developments
11 Appendix
11.1 Publisher Expertise
11.2 Research Methodology
11.3 Annual Subscription Plans
11.4 Contact Information
Get Free Sample
At OG Analysis, we understand the importance of informed decision-making in today's dynamic business landscape. To help you experience the depth and quality of our market research reports, we offer complimentary samples tailored to your specific needs.
Start Now! Please fill the form below for your free sample.
Why Request a Free Sample?
Evaluate Our Expertise: Our reports are crafted by industry experts and seasoned analysts. Requesting a sample allows you to assess the depth of research and the caliber of insights we provide.
Tailored to Your Needs: Let us know your industry, market segment, or specific topic of interest. Our free samples are customized to ensure relevance to your business objectives.
Witness Actionable Insights: See firsthand how our reports go beyond data, offering actionable insights and strategic recommendations that can drive your business forward.
Embark on your journey towards strategic decision-making by requesting a free sample from OG Analysis. Experience the caliber of insights that can transform the way you approach your business challenges.
FAQ's
The Global Pharmaceutical Gelatin Market is estimated to generate USD 1.73 billion in revenue in 2025.
The Global Pharmaceutical Gelatin Market is expected to grow at a Compound Annual Growth Rate (CAGR) of 6.73% during the forecast period from 2025 to 2034.
The Pharmaceutical Gelatin Market is estimated to reach USD 3.1 billion by 2034.
$3950- 5%
$6450- 10%
$8450- 15%
Didn’t find what you’re looking for? TALK TO OUR ANALYST TEAM
Need something within your budget? NO WORRIES! WE GOT YOU COVERED!
